JP2013541562A5 - - Google Patents

Download PDF

Info

Publication number
JP2013541562A5
JP2013541562A5 JP2013536924A JP2013536924A JP2013541562A5 JP 2013541562 A5 JP2013541562 A5 JP 2013541562A5 JP 2013536924 A JP2013536924 A JP 2013536924A JP 2013536924 A JP2013536924 A JP 2013536924A JP 2013541562 A5 JP2013541562 A5 JP 2013541562A5
Authority
JP
Japan
Prior art keywords
carrier material
therapeutic agent
composition
syringe
porous silicon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013536924A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013541562A (ja
JP6026424B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/058774 external-priority patent/WO2012061377A1/en
Publication of JP2013541562A publication Critical patent/JP2013541562A/ja
Publication of JP2013541562A5 publication Critical patent/JP2013541562A5/ja
Application granted granted Critical
Publication of JP6026424B2 publication Critical patent/JP6026424B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013536924A 2010-11-01 2011-11-01 治療薬送達のための生物浸食性ケイ素ベースのデバイス Expired - Fee Related JP6026424B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US40893410P 2010-11-01 2010-11-01
US61/408,934 2010-11-01
US201161470299P 2011-03-31 2011-03-31
US61/470,299 2011-03-31
PCT/US2011/058774 WO2012061377A1 (en) 2010-11-01 2011-11-01 Bioerodible silicon-based devices for delivery of therapeutic agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016019772A Division JP6189460B2 (ja) 2010-11-01 2016-02-04 治療薬送達のための生物浸食性ケイ素ベースのデバイス

Publications (3)

Publication Number Publication Date
JP2013541562A JP2013541562A (ja) 2013-11-14
JP2013541562A5 true JP2013541562A5 (enExample) 2015-01-08
JP6026424B2 JP6026424B2 (ja) 2016-11-16

Family

ID=46024803

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013536924A Expired - Fee Related JP6026424B2 (ja) 2010-11-01 2011-11-01 治療薬送達のための生物浸食性ケイ素ベースのデバイス
JP2016019772A Expired - Fee Related JP6189460B2 (ja) 2010-11-01 2016-02-04 治療薬送達のための生物浸食性ケイ素ベースのデバイス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016019772A Expired - Fee Related JP6189460B2 (ja) 2010-11-01 2016-02-04 治療薬送達のための生物浸食性ケイ素ベースのデバイス

Country Status (11)

Country Link
US (3) US9333173B2 (enExample)
EP (1) EP2635255B1 (enExample)
JP (2) JP6026424B2 (enExample)
CN (4) CN103282020B (enExample)
AU (2) AU2011323524B2 (enExample)
CA (1) CA2816576C (enExample)
HK (3) HK1210048A1 (enExample)
IN (1) IN2013MN00758A (enExample)
RU (1) RU2640918C2 (enExample)
TW (1) TWI615150B (enExample)
WO (1) WO2012061377A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9808052D0 (en) 1998-04-17 1998-06-17 Secr Defence Implants for administering substances and methods of producing implants
EP2427179A4 (en) 2009-05-04 2013-09-11 Psivida Inc POROUS SILICON MEDICATION ELUTING PARTICLES
CN103282020B (zh) 2010-11-01 2016-10-26 普西维达公司 用于递送治疗剂的可生物侵蚀的硅基装置
WO2014165108A1 (en) * 2013-03-12 2014-10-09 Psivida Us, Inc. Bioerodible silicon-based delivery vehicles for delivery of therapeutic agents
RU2695536C2 (ru) * 2013-03-12 2019-07-23 Айпоинт Фармасьютикалз Юэс, Инк. Устройство для доставки лекарственных средств, содержащее частицы носителя на основе кремния
AU2014235051B2 (en) * 2013-03-15 2019-01-17 Eyepoint Pharmaceuticals Us, Inc. Bioerodible silicon-based compositions for delivery of therapeutic agents
US20160075776A1 (en) * 2014-09-16 2016-03-17 Paul Ashton Compositions and Methods for Controlled Release of Agents
JP6883257B2 (ja) * 2017-05-16 2021-06-09 株式会社豊田中央研究所 還元反応用固体触媒
EP3810083A1 (en) 2018-06-19 2021-04-28 Cella Therapeutics, LLC Drug delivery systems comprising a neurotrophic agent, an apoptosis signaling fragment inhibitor (fas) or fas ligand (fasl) inhibitor, a tumor necrosis factor-? (tnf-?) or tnf receptor inhibitor, a mitochondrial peptide, an oligonucleotide, a chemokine inhibitor, or a cysteine-aspartic protease
CN112566622A (zh) 2018-06-19 2021-03-26 细胞疗法有限责任公司 用于治疗青光眼或高眼压症的包含眼内压降低剂、cnp化合物、npr-b化合物、tie-2激动剂或神经营养剂的缓释药物递送系统
EA202092684A1 (ru) 2018-08-27 2021-03-11 Ридженерон Фармасьютикалз, Инк. Применение рамановской спектроскопии для последующей очистки
CN114948864A (zh) * 2021-02-26 2022-08-30 奈力生医股份有限公司 用于将药剂递送到眼后段的方法和其用途
TWI803092B (zh) * 2021-04-01 2023-05-21 逢甲大學 具負載與釋放活性成分的奈米粒子、其製造方法與眼用裝置之應用

Family Cites Families (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3832458A (en) 1971-12-06 1974-08-27 River C Foundation Hydrophilic silicone composition and method
US4036979A (en) 1974-01-25 1977-07-19 American Cyanamid Company Compositions containing 4,5,6,7-tetrahydrobenz[b]thien-4-yl-ureas or derivatives and methods of enhancing growth rate
US3919723A (en) 1974-05-20 1975-11-18 Friedrichsfeld Gmbh Bone shaft or bone joint prosthesis and process
US3919060A (en) 1974-06-14 1975-11-11 Ibm Method of fabricating semiconductor device embodying dielectric isolation
DE3214667C2 (de) 1982-04-21 1985-07-18 Akzo Gmbh, 5600 Wuppertal Zusammengesetzter Körper für die Langzeitabgabe von Wirkstoffen
JPS59101145A (ja) 1982-11-30 1984-06-11 日本特殊陶業株式会社 薬液含浸多孔質セラミツクス
JPS59131346A (ja) 1983-01-17 1984-07-28 日本特殊陶業株式会社 薬液含浸多孔質セラミツクスの製造法
DE3423667A1 (de) 1984-05-08 1985-11-28 Rüdiger Dipl.-Ing. 5204 Lohmar Scheunemann Implantat fuer knochen- und zahnwurzelersatz mit spezieller uebergangsstruktur zwischen knochen und implantatkern und knochenseitig ganz oder teilweise resorbierbarer matrix
GB8422876D0 (en) 1984-09-11 1984-10-17 Secr Defence Silicon implant devices
US4608048A (en) 1984-12-06 1986-08-26 Alza Corporation Dispensing device with drug delivery patterns
US5057082A (en) 1988-11-04 1991-10-15 Plastic Injectors, Inc. Trocar assembly
ES2042292T3 (es) 1989-03-17 1993-12-01 Pitman-Moore, Inc. Dispositivo de administracion de proteinas macromoleculares por liberacion controlada.
US5167625A (en) 1990-10-09 1992-12-01 Sarcos Group Multiple vesicle implantable drug delivery system
AU665067B2 (en) * 1992-04-30 1995-12-14 Takeda Pharmaceutical Company Limited Prefilled syringe
US5366454A (en) 1993-03-17 1994-11-22 La Corporation De L'ecole Polytechnique Implantable medication dispensing device
US5370630A (en) 1993-11-12 1994-12-06 Smidebush; Michael J. Device for injection of fluidic materials into body tissue
US5489266A (en) * 1994-01-25 1996-02-06 Becton, Dickinson And Company Syringe assembly and method for lyophilizing and reconstituting injectable medication
US5558071A (en) 1994-03-07 1996-09-24 Combustion Electromagnetics, Inc. Ignition system power converter and controller
US5817327A (en) 1994-07-27 1998-10-06 The Trustees Of The University Of Pennsylvania Incorporation of biologically active molecules into bioactive glasses
US5591453A (en) 1994-07-27 1997-01-07 The Trustees Of The University Of Pennsylvania Incorporation of biologically active molecules into bioactive glasses
US5665114A (en) 1994-08-12 1997-09-09 Meadox Medicals, Inc. Tubular expanded polytetrafluoroethylene implantable prostheses
US5792099A (en) 1995-02-14 1998-08-11 Decamp; Dennis Syringe and cannula for insertion of viscoelastic material into an eye and method of using same
WO1996031197A1 (en) 1995-04-03 1996-10-10 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
US6096344A (en) 1995-07-28 2000-08-01 Advanced Polymer Systems, Inc. Bioerodible porous compositions
GB9611437D0 (en) 1995-08-03 1996-08-07 Secr Defence Biomaterial
US5665428A (en) 1995-10-25 1997-09-09 Macromed, Inc. Preparation of peptide containing biodegradable microspheres by melt process
DE19608423A1 (de) 1996-03-05 1997-09-11 Merck Patent Gmbh Implantate mit phasenweiser Arzneistoffabgabe
FR2749169B1 (fr) * 1996-06-04 1998-08-21 Delab Procede pour constituer une preparation injectable et dispositif pour la mise en oeuvre de ce procede
US5797898A (en) 1996-07-02 1998-08-25 Massachusetts Institute Of Technology Microchip drug delivery devices
US7070590B1 (en) 1996-07-02 2006-07-04 Massachusetts Institute Of Technology Microchip drug delivery devices
US5922299A (en) 1996-11-26 1999-07-13 Battelle Memorial Institute Mesoporous-silica films, fibers, and powders by evaporation
JP3217286B2 (ja) * 1996-12-19 2001-10-09 科学技術振興事業団 Ｄｎａ固定化複合体
WO1999036357A1 (en) 1998-01-20 1999-07-22 Drexel University Mesoporous materials and methods of making the same
US6696258B1 (en) 1998-01-20 2004-02-24 Drexel University Mesoporous materials and methods of making the same
US6060036A (en) 1998-02-09 2000-05-09 Implant Sciences Corporation Radioactive seed implants
GB9808052D0 (en) 1998-04-17 1998-06-17 Secr Defence Implants for administering substances and methods of producing implants
GB9815819D0 (en) 1998-07-22 1998-09-16 Secr Defence Transferring materials into cells and a microneedle array
ATE306250T1 (de) 1998-12-23 2005-10-15 Alza Corp Dosierungsformen, die poröse partikel enthalten
WO2000040089A1 (en) * 1999-01-05 2000-07-13 Massachusetts Eye And Ear Infirmary Targeted transscleral controlled release drug delivery to the retina and choroid
CA2380941A1 (en) 1999-08-16 2001-02-22 Henceforth Hibernia, Inc. Therapeutic and prophylactic compositions including catalytic biomimetic solids and methods to prepare and use them
GB9924334D0 (en) 1999-10-15 1999-12-15 Secr Defence Pharmaceutical products and methods of fabrication therefor
KR20020064299A (ko) * 1999-10-18 2002-08-07 퍽스 인코포레이티드 자기 표적화형 캐리어
SE9903958D0 (sv) 1999-11-02 1999-11-02 Boerje Sellergren Porous materials for selective binding or transport of molecular guests
US6521284B1 (en) 1999-11-03 2003-02-18 Scimed Life Systems, Inc. Process for impregnating a porous material with a cross-linkable composition
AUPQ573300A0 (en) 2000-02-21 2000-03-16 Australian Nuclear Science & Technology Organisation Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
NZ520593A (en) 2000-02-28 2004-10-29 Aventis Pharma S A composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer
IL134830A0 (en) 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
EP1267912A2 (en) 2000-03-14 2003-01-02 Burkhard Göke Effects of glucagon-like peptide-1 (7-36) on antro-pyloro-duodenal motility
GB0008494D0 (en) * 2000-04-07 2000-05-24 Secr Defence Microprojectile delivery system
GB2365769A (en) 2000-08-18 2002-02-27 Secr Defence Skin preparations containing silicon
GB0104383D0 (en) 2001-02-22 2001-04-11 Psimedica Ltd Cancer Treatment
US6973718B2 (en) 2001-05-30 2005-12-13 Microchips, Inc. Methods for conformal coating and sealing microchip reservoir devices
AU2003258414A1 (en) 2002-08-23 2004-03-11 Mcmaster University Methods and compounds for controlling the morphology and shrinkage of silica derived from polyol-modified silanes
CN1301692C (zh) 2002-09-18 2007-02-28 阿勒根公司 眼植入物导入的器械
US7713778B2 (en) 2003-02-13 2010-05-11 Univ California Nanostructured casting of organic and bio-polymers in porous silicon templates
US7433811B2 (en) 2003-05-06 2008-10-07 The Regents Of The University Of California Direct patterning of silicon by photoelectrochemical etching
US7563451B2 (en) 2003-07-22 2009-07-21 Iowa State University Research Foundation, Inc. Capped mesoporous silicates
SI1677828T1 (sl) 2003-10-21 2013-04-30 Psimedica Limited Kompozitni material, ki vsebuje porozen polprevodnik impregniran z organsko substanco
GB0324483D0 (en) * 2003-10-21 2003-11-19 Psi Medica Ltd Composite material
US20050181049A1 (en) 2003-11-19 2005-08-18 Dong Liang C. Composition and method for enhancing bioavailability
JP2008513127A (ja) 2004-09-17 2008-05-01 オルムコ コーポレイション 医療装置及び針製造方法
US20060067979A1 (en) 2004-09-30 2006-03-30 Bausch & Lomb Incorporated Ophthalmic drug release device for multiple drug release
CA2583054A1 (en) * 2004-10-05 2006-04-13 The University Of Melbourne Porous polyelectrolyte materials
US20090208556A1 (en) 2004-10-29 2009-08-20 Regents Of The University Of California, The Porous photonic crystals for drug delivery to the eye
JP4977475B2 (ja) 2004-12-21 2012-07-18 日本電気株式会社 フィルム外装電気デバイス用ケース
JP2007091716A (ja) 2005-08-29 2007-04-12 Kuraray Co Ltd 水中薬剤徐放性微粒子及びその製造方法
GB0526332D0 (en) 2005-12-23 2006-02-01 Psimedica Ltd Pharmaceutical product
US8119394B2 (en) 2006-03-14 2012-02-21 University Of Rochester Cell culture devices having ultrathin porous membrane and uses thereof
KR101062796B1 (ko) 2006-03-31 2011-09-06 큐엘티 인코포레이티드 약물 요법을 위한 비루관 배출계 임플란트
JP4984644B2 (ja) * 2006-05-19 2012-07-25 株式会社ジェイ・エム・エス 注射装置
US20080057102A1 (en) * 2006-08-21 2008-03-06 Wouter Roorda Methods of manufacturing medical devices for controlled drug release
KR101329658B1 (ko) 2006-09-25 2013-11-14 아처 다니엘 미드랜드 캄파니 초흡수성 표면처리된 카르복시알킬화 다당류 및 그 제조방법
JP5141948B2 (ja) * 2007-07-09 2013-02-13 株式会社豊田中央研究所 バイモダルな細孔構造を有する球状シリカ系メソ多孔体及びその製造方法
NZ583120A (en) 2007-07-10 2012-03-30 Univ California Materials and methods for delivering compositions to selected tissues
US20130084243A1 (en) 2010-01-27 2013-04-04 Liliane Goetsch Igf-1r specific antibodies useful in the detection and diagnosis of cellular proliferative disorders
EP2889029A1 (en) 2008-09-25 2015-07-01 Cephalon, Inc. Liquid formulations of bendamustine
GB0817938D0 (en) * 2008-09-30 2008-11-05 Intrinsiq Materials Global Ltd Cosmetic formulations
GB0817936D0 (en) * 2008-09-30 2008-11-05 Intrinsiq Materials Global Ltd Porous materials
JP5369725B2 (ja) 2009-01-30 2013-12-18 株式会社ニコン 撮像装置
WO2010090596A1 (en) * 2009-02-04 2010-08-12 Agency For Science, Technology And Research Hollow silica particle with a polymer thereon
WO2010096733A2 (en) 2009-02-20 2010-08-26 The Regents Of The University Of California Luminescent porous silicon nanoparticles, methods of making and using same
WO2010111627A1 (en) 2009-03-26 2010-09-30 Psivida Us, Inc. Implantable formulations of bisphosphonic acids
JP5382700B2 (ja) * 2009-03-27 2014-01-08 独立行政法人産業技術総合研究所 ロッド状多孔質シリカ粒子
EP2427179A4 (en) 2009-05-04 2013-09-11 Psivida Inc POROUS SILICON MEDICATION ELUTING PARTICLES
US20110028412A1 (en) 2009-08-03 2011-02-03 Cappellos, Inc. Herbal enhanced analgesic formulations
DE102010008982A1 (de) 2010-02-24 2011-08-25 Bayer Innovation GmbH, 40225 Siliciumhaltiges, biologisch degradierbares Material zur anti-inflammatorischen Therapie
GB201017048D0 (en) 2010-10-08 2010-11-24 Ucl Business Plc Composition
CN103282020B (zh) 2010-11-01 2016-10-26 普西维达公司 用于递送治疗剂的可生物侵蚀的硅基装置
US20120238993A1 (en) 2010-12-22 2012-09-20 Martin Nazzaro Two-piece injectable drug delivery device with heat-cured seal
WO2012109673A1 (en) 2011-02-11 2012-08-16 Psivida Us, Inc. Methods of treating macular edema using antiedema therapeutics
CA2830654A1 (en) 2011-03-31 2012-10-04 Galderma Research & Development Compositions comprising a filler product and at least one bioresorbable and biodegradable silica-based material
DK2750660T3 (en) 2011-08-29 2016-12-12 Mati Therapeutics Inc FILING WITH PROLONGED RELEASE OF ACTIVE AGENTS to treat glaucoma and ocular hypertension
SG11201504022RA (en) 2012-11-21 2015-06-29 Agios Pharmaceuticals Inc Glutamase inhibitors and method of use
WO2014165108A1 (en) 2013-03-12 2014-10-09 Psivida Us, Inc. Bioerodible silicon-based delivery vehicles for delivery of therapeutic agents
WO2016077632A2 (en) 2014-11-13 2016-05-19 Buck Institute For Research On Aging Inhibition of proline catabolism for the treatment of cancer and other therapeutic applications

Similar Documents

Publication Publication Date Title
JP2013541562A5 (enExample)
RU2013119438A (ru) Биоразлагаемые устройства на основе кремния для доставки терапевтических агентов
RU2015132217A (ru) Биоразлагаемые композиции на основе кремния для доставки терапевтических агентов
Febinger et al. Time-dependent effects of CX3CR1 in a mouse model of mild traumatic brain injury
Martin et al. Tailoring width of microfabricated nanochannels to solute size can be used to control diffusion kinetics
JP2016512839A5 (enExample)
Liu et al. Improvement of transdermal delivery of exendin-4 using novel tip-loaded microneedle arrays fabricated from hyaluronic acid
ES2955029T3 (es) Medicamento para la cicatrización de heridas
Yang et al. Polymorph control of micro/nano-sized mefenamic acid crystals on patterned self-assembled monolayer islands
KR102371745B1 (ko) 방출가능한 도펀트를 갖는 세라믹 입자들을 함유하는 나노섬유질 매트
US9474756B2 (en) Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
Soontornworajit et al. Aptamer-functionalized in situ injectable hydrogel for controlled protein release
AU2023248183A1 (en) PDX1 pancreatic endoderm cells in cell delivery devices and methods thereof
Jung et al. siRNA targeting Hes5 augments hair cell regeneration in aminoglycoside-damaged mouse utricle
Azizi et al. Imatinib mesylate: an innovation in treatment of autoimmune diseases
CN106668840B (zh) 一种胰岛素控释药物及其制备方法与应用
JP2019510562A (ja) バイオ人工限外濾過装置及びそれに関連する方法
JP2011523650A (ja) ケトチフェン経皮薬物送達システム及び眼科疾患の治療方法
Zhong et al. Study on poly (D, L‐lactic) microspheres embedded in calcium alginate hydrogel beads as dual drug delivery systems
Zhang et al. Programmable bispecific nano-immunoengager that captures T cells and reprograms tumor microenvironment
Hutton et al. Enhancing the transdermal delivery of ‘next generation’variable new antigen receptors using microarray patch technology: a proof-of-concept study
Sharma et al. Toroidal-spiral particles for codelivery of anti-VEGFR-2 antibody and irinotecan: a potential implant to hinder recurrence of glioblastoma multiforme
Xie et al. Dissolvable Core–Shell Microneedle Patch for Biphasic Drug Delivery To Enhance Diabetic Wound Healing
CN114222589A (zh) 耳内给药用药物组合物
US20230040370A1 (en) Graphene bioscaffolds and their use in cellular therapy